THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Elizabeth Hile

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
3
2024
818
0.950
 Why?
Diabetic Neuropathies
1
2024
14
0.870
 Why?
Hallux
1
2023
3
0.840
 Why?
Athletic Performance
1
2023
46
0.810
 Why?
Sarcopenia
1
2022
42
0.740
 Why?
Resistance Training
1
2022
212
0.640
 Why?
Gait
4
2012
61
0.580
 Why?
Postural Balance
3
2012
41
0.560
 Why?
Disability Evaluation
4
2012
54
0.520
 Why?
Geriatric Assessment
3
2012
88
0.480
 Why?
Gait Disorders, Neurologic
1
2010
9
0.350
 Why?
Peripheral Nervous System Diseases
1
2010
18
0.340
 Why?
Antineoplastic Agents, Phytogenic
1
2010
55
0.330
 Why?
Aged
9
2023
5416
0.320
 Why?
Exercise Therapy
2
2022
84
0.320
 Why?
Paclitaxel
1
2010
190
0.320
 Why?
Female
10
2024
15156
0.240
 Why?
Humans
12
2024
28121
0.220
 Why?
Breast
1
2024
54
0.210
 Why?
Toes
1
2023
3
0.210
 Why?
Artificial Intelligence
1
2024
54
0.210
 Why?
Mobility Limitation
3
2011
15
0.200
 Why?
Lower Extremity
1
2023
84
0.190
 Why?
Longevity
1
2023
134
0.190
 Why?
Preoperative Care
1
2022
82
0.180
 Why?
Motor Activity
2
2013
147
0.180
 Why?
Muscle Strength
1
2022
230
0.170
 Why?
Cancer Survivors
1
2020
43
0.160
 Why?
Activities of Daily Living
1
2020
109
0.160
 Why?
Injections, Epidural
1
2019
3
0.160
 Why?
Musculoskeletal Manipulations
1
2019
5
0.150
 Why?
Conservative Treatment
1
2019
11
0.150
 Why?
Male
8
2023
13487
0.150
 Why?
Spinal Stenosis
1
2019
15
0.150
 Why?
Medication Therapy Management
1
2019
18
0.150
 Why?
Lumbar Vertebrae
1
2019
124
0.140
 Why?
Quality of Life
2
2020
491
0.140
 Why?
Cross-Sectional Studies
4
2013
968
0.130
 Why?
Aging
1
2024
976
0.130
 Why?
Accidental Falls
2
2013
32
0.130
 Why?
Fear
2
2013
60
0.120
 Why?
Young Adult
1
2023
2731
0.120
 Why?
Surveys and Questionnaires
3
2013
969
0.110
 Why?
Walking
2
2011
135
0.100
 Why?
Body Mass Index
2
2011
398
0.100
 Why?
Data Interpretation, Statistical
1
2012
58
0.100
 Why?
Aged, 80 and over
3
2011
2021
0.090
 Why?
Psychometrics
1
2011
121
0.090
 Why?
Adult
1
2023
7757
0.090
 Why?
Dancing
1
2010
16
0.090
 Why?
Video Games
1
2010
20
0.090
 Why?
Mastectomy
1
2010
21
0.090
 Why?
Exercise Test
1
2011
248
0.090
 Why?
Health Promotion
1
2010
176
0.080
 Why?
Middle Aged
3
2019
7164
0.070
 Why?
Breast Neoplasms
1
2010
464
0.060
 Why?
Linear Models
2
2013
203
0.050
 Why?
Self Report
2
2013
120
0.050
 Why?
Analysis of Variance
2
2011
390
0.040
 Why?
Health Surveys
1
2020
82
0.040
 Why?
Ambulatory Care Facilities
1
2019
54
0.040
 Why?
Age Factors
1
2020
733
0.040
 Why?
Tomography, X-Ray Computed
1
2019
477
0.030
 Why?
Magnetic Resonance Imaging
1
2019
825
0.030
 Why?
Accelerometry
1
2013
12
0.030
 Why?
Treatment Outcome
1
2020
2380
0.030
 Why?
Task Performance and Analysis
1
2011
43
0.020
 Why?
Observation
1
2011
5
0.020
 Why?
Self Disclosure
1
2011
6
0.020
 Why?
Chi-Square Distribution
1
2011
145
0.020
 Why?
Self Efficacy
1
2011
77
0.020
 Why?
Housing for the Elderly
1
2010
2
0.020
 Why?
Social Participation
1
2010
4
0.020
 Why?
Patient Compliance
1
2010
75
0.020
 Why?
Comorbidity
1
2011
256
0.020
 Why?
Predictive Value of Tests
1
2011
475
0.020
 Why?
Feasibility Studies
1
2010
193
0.020
 Why?
Health Status
1
2010
148
0.020
 Why?
Reproducibility of Results
1
2011
773
0.020
 Why?
Prospective Studies
1
2011
1249
0.020
 Why?
Hile's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Co-Authors (1)
Explore
_
Similar People (56)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES